Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model☆,☆☆,★
Section snippets
Material and methods
The placentas used in this study were collected from term, uncomplicated deliveries in accordance with the guidelines set forth by the University of Texas Southwestern Medical Center Institutional Review Board for Human Studies. The placentas were transferred from our labor and delivery suite to the laboratory in normal saline. On arrival of the placenta to the laboratory, the truncal branch of the chorionic artery supplying a selected cotyledon and the associated vein were cannulated with 3.0F
Results
Reproducibility studies provided recoveries between 86.4% and 106.5%, with a correlation coefficient >0.9973. Minimum sensitivity of the high-pressure liquid chromatographic assay is 0.025 μg/mL. Transport fraction and clearance index of ritonavir were determined at trough (1 to 2 μg/mL) and peak (20 μg/mL) levels. At trough level the concentration of ritonavir in the fetal circulation was below the minimum sensitivity of the high-pressure liquid chromatographic assay (<0.025 μg/mL) in all but
Comment
As stated earlier, approximately 90% of all HIV infection in children is the result of vertical transmission. It has previously been shown that antepartum zidovudine treatment of the mother and treatment of her neonate can reduce transmission by up to 80%.18 There are, however, minimal data available on the pharmacokinetics and safety of other antiretroviral agents during pregnancy.19 Additionally, despite the success of zidovudine monotherapy in preventing perinatal transmission, concerns for
References (19)
HIV infection in women
Primary Care Update Ob/Gyn
(1996)- et al.
Risk of human immunodeficiency virus type 1 transmission through breastfeeding
Lancet
(1992) - et al.
Antiretroviral therapy for pregnant women
Am J Obstet Gynecol
(1997) Antiretroviral drugs for AIDS
Lancet
(1996)- et al.
Safety and activity of saquinavir in HIV infection
Lancet
(1995) - et al.
The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta
Am J Obstet Gynecol
(1992) - et al.
Postnatal transmission of human immunodeficiency virus type I from mother to infant
N Engl J Med
(1991) Breast feeding and HIV
Lancet
(1993)- et al.
Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment
N Engl J Med
(1994)
Cited by (0)
- ☆
From the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center.
- ☆☆
Reprint requests: Brian M. Casey, MD, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9032.
- ★
0002-9378/98 $5.00 +0 6/1/89559